Clinical Trials Browser

Phase 2/3 × Hyperthermia × 90 days × Clear all

NCT05889390 2026-05-15

NeoHTerMa

Phase 2/3 Active not recruiting

Hyperthermia, Breast Neoplasms

NCT02758951 2026-03-24

CAIRO6

Phase 2/3 Active not recruiting

GastrointestinalGynecologic

Hyperthermia, Colonic Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms